Beyond the Inhaler: How Biologics, Phenotyping, and the Pursuit of Remission Are Redefining Airway Disease.

Abstract excerpt

Airway disease management is undergoing a structural transformation. For decades, asthma was treated as a single condition with a stepwise escalation of inhaled therapies, an approach that left the most severe cases cycling through treatments misaligned with their underlying biology. Updated global guidelines from the Global Initiative for Asthma (GINA) and ARIA-EAACI have shifted the field toward precision,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Asthma
• Share to Biological Products
• Share to Phenotype